2000
DOI: 10.1006/frne.1999.0194
|View full text |Cite
|
Sign up to set email alerts
|

Melatonin and Mammary Pathological Growth

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

7
162
0
2

Year Published

2001
2001
2016
2016

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 162 publications
(171 citation statements)
references
References 135 publications
7
162
0
2
Order By: Relevance
“…In these studies, optimal blastocyst rates were achieved when physiological melatonin rates (Cos and Sanchez-Barceló, 2000), which varied from 10 -9 M to 10 -6 M, were added to culture media. In the present study, a concentration of melatonin close to physiological levels (10 -9 M) was tested because elevated concentrations of melatonin negatively affect follicle survival in culture (Adriaens et al, 2006).…”
Section: Resultsmentioning
confidence: 99%
“…In these studies, optimal blastocyst rates were achieved when physiological melatonin rates (Cos and Sanchez-Barceló, 2000), which varied from 10 -9 M to 10 -6 M, were added to culture media. In the present study, a concentration of melatonin close to physiological levels (10 -9 M) was tested because elevated concentrations of melatonin negatively affect follicle survival in culture (Adriaens et al, 2006).…”
Section: Resultsmentioning
confidence: 99%
“…In the absence of estradiol (E2), the inactive receptor is complexed with a variety of proteins that block its ability to interact with DNA whereas in the presence of E2, the receptor undergoes a conformational change that allows its binding to coactivators, initiating the transcription of target genes. Melatonin downregulates ER expression by suppressing ER gene transcription, resulting in a reduction in ER mRNA and protein levels [125,126]. Melatonin also inhibits the mitogenic effects of E2 in cancer cells by blocking its ability to stimulate binding of ER to DNA: melatonin inhibits binding of the E2-ER complex to the estrogen response element (ERE) on DNA [38].…”
Section: Anti-estrogenic Activitiesmentioning
confidence: 99%
“…In such perspective, it might be worth to better characterize this issue with the aim of designing efficient ionic channel inhibitors/modulators that may potentially affect cancer therapy. Functional relationship exists between resting membrane potential, K þ channel type expression and cell functions such as proliferation and differentiation (Asher et al, 2010;Cos and Sánchez-Barceló, 2003;Enomoto et al, 1986;Wang, 2004). Resting membrane potential is typically more depolarized in undifferentiated respect to differentiated cells (O'Grady and Lee, 2005;Pardo, 2004) and in cancer cells respect to terminally differentiated cells (Kunzelmann, 2005).…”
Section: Introductionmentioning
confidence: 99%